Literature DB >> 23160587

Therapeutic drug monitoring (TDM) repertoire in Norway.

Andreas Austgulen Westin1, Ruth-Anne Larsen, Ketil Arne Espnes, Olav Spigset.   

Abstract

BACKGROUND: In many clinical situations it is useful to measure drug levels in patient samples. The purpose of this survey is to obtain an overview of the therapeutic drug monitoring analyses offered by Norwegian laboratories. MATERIAL AND
METHOD: At the end of 2011, the authors of this article phoned all the public and private hospitals in Norway, and located their laboratories. All clinical chemical and pharmacological laboratories were contacted and asked to state which drug analyses (including drugs-of-abuse and toxic alcohols, but excluding metabolites) they performed in blood/serum at the time in question. The overview thus obtained was updated and quality assured by means of further telephone contact with the laboratories in August 2012.
RESULTS: Around 80 laboratories were contacted. In August 2012, 49 of them performed analyses of drugs in blood/serum. Altogether, these laboratories offered 151 different analyses. This article provides an overview of the analyses that were carried out, and where.
INTERPRETATION: The overview of analyses provided here can be used as a tool in everyday practice. However, the user must be aware that the analytical repertoire of the laboratories is constantly changing. A web-based, dynamic version is currently being planned.

Entities:  

Mesh:

Year:  2012        PMID: 23160587     DOI: 10.4045/tidsskr.12.0383

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  5 in total

1.  Prevalence of Therapeutic Drug Monitoring for Antidepressants and Antipsychotics in Stockholm, Sweden: A Longitudinal Analysis.

Authors:  Susanna M Wallerstedt; Jonatan D Lindh
Journal:  Ther Drug Monit       Date:  2015-08       Impact factor: 3.681

2.  Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.

Authors:  Andreas Austgulen Westin; Malin Brekke; Espen Molden; Eirik Skogvoll; Olav Spigset
Journal:  PLoS One       Date:  2017-07-14       Impact factor: 3.240

3.  Treatment With Antipsychotics in Pregnancy: Changes in Drug Disposition.

Authors:  Andreas A Westin; Malin Brekke; Espen Molden; Eirik Skogvoll; Ingrid Castberg; Olav Spigset
Journal:  Clin Pharmacol Ther       Date:  2017-09-19       Impact factor: 6.875

4.  Serum or Plasma for Quantification of Direct Oral Anticoagulants?

Authors:  Rachel Aakerøy; Charlotte L Stokes; Marija Tomić; Solfrid Hegstad; Ann Helen Kristoffersen; Hanne Ellekjær; Jan Schjøtt; Olav Spigset; Arne Helland
Journal:  Ther Drug Monit       Date:  2022-01-20       Impact factor: 3.118

5.  Sampling time and indications appropriateness for therapeutically monitored drugs at a teaching university hospital in Oman.

Authors:  Mohammed Al Za'abi; Juhina Al Muqbali; Khalid Al-Waili
Journal:  Saudi Pharm J       Date:  2014-11-24       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.